NO20054646L - Doseringskur for ikke-steroidalt anti-inflammatorisk legemiddel - Google Patents

Doseringskur for ikke-steroidalt anti-inflammatorisk legemiddel

Info

Publication number
NO20054646L
NO20054646L NO20054646A NO20054646A NO20054646L NO 20054646 L NO20054646 L NO 20054646L NO 20054646 A NO20054646 A NO 20054646A NO 20054646 A NO20054646 A NO 20054646A NO 20054646 L NO20054646 L NO 20054646L
Authority
NO
Norway
Prior art keywords
steroidal anti
inflammatory drug
dosage course
dosage
course
Prior art date
Application number
NO20054646A
Other languages
English (en)
Norwegian (no)
Inventor
Gerard P Mcnally
Cathy K Gelotte
Douglas R Hough
Original Assignee
Mcneil Ppc Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mcneil Ppc Inc filed Critical Mcneil Ppc Inc
Publication of NO20054646L publication Critical patent/NO20054646L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/38—Heterocyclic compounds having sulfur as a ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
NO20054646A 2003-03-21 2005-10-10 Doseringskur for ikke-steroidalt anti-inflammatorisk legemiddel NO20054646L (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/US2003/008846 WO2004093864A1 (fr) 2003-03-21 2003-03-21 Regime posologique pour anti-inflammatoires non steroidiens

Publications (1)

Publication Number Publication Date
NO20054646L true NO20054646L (no) 2005-10-10

Family

ID=33308979

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20054646A NO20054646L (no) 2003-03-21 2005-10-10 Doseringskur for ikke-steroidalt anti-inflammatorisk legemiddel

Country Status (10)

Country Link
EP (1) EP1605929B1 (fr)
JP (1) JP2006514982A (fr)
KR (1) KR101113005B1 (fr)
CN (1) CN1758904A (fr)
AU (2) AU2003220467A1 (fr)
BR (1) BR0318201A (fr)
CA (2) CA2519772C (fr)
MX (1) MXPA05010010A (fr)
NO (1) NO20054646L (fr)
WO (1) WO2004093864A1 (fr)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2696063C (fr) 2007-08-15 2014-05-06 Mcneil-Ppc, Inc. Schema posologique d'ibuprofene a liberation immediate et a liberation continue
US9119878B2 (en) 2010-07-08 2015-09-01 Wellesley Pharmaceuticals, Llc Extended-release formulation for reducing the frequency of urination and method of use thereof
US20130225685A1 (en) 2010-11-04 2013-08-29 Aft Pharmaceuticals Limited Combination composition
CN107157991A (zh) * 2012-03-19 2017-09-15 韦尔斯利医药有限公司 用于缓解尿频的延长释放制剂及其使用方法
US10596127B2 (en) 2013-03-14 2020-03-24 Wellesley Pharmaceuticals, Llc Composition for reducing the frequency of urination, method of making and use thereof
AU2016317093A1 (en) * 2015-09-01 2018-04-26 Wellesley Pharmaceuticals, Llc Delayed-release formulations, methods of making and use thereof
KR20220113567A (ko) 2021-02-05 2022-08-16 이광미 염증 질환의 개선용 조성물
KR20240044914A (ko) 2022-09-29 2024-04-05 이광미 금속 티오옥토일 히알루로네이트 복합체를 포함하는 염증 질환의 개선용 조성물

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2998450A (en) 1958-05-19 1961-08-29 Warner Lambert Pharmaceutical Process of preparing nu-acetyl-p-amino phenol
GB1497044A (en) 1974-03-07 1978-01-05 Prodotti Antibiotici Spa Salts of phenyl-alkanoic acids
US4873231A (en) 1986-04-08 1989-10-10 Smith Walton J Decreasing the toxicity of an ibuprofen salt
CA2061520C (fr) 1991-03-27 2003-04-22 Lawrence J. Daher Systeme de delivrance accelerant l'effet et accroissant la puissance
IT1264855B1 (it) 1993-06-21 1996-10-17 Zambon Spa Composizioni farmaceutiche contenenti sali dell'acido s(+)-2-(4-isobutilfenil) propionico con amminoacidi basici
IT1276689B1 (it) 1995-06-09 1997-11-03 Applied Pharma Res Forma farmaceutica solida ad uso orale

Also Published As

Publication number Publication date
BR0318201A (pt) 2006-03-21
CA2746531A1 (fr) 2004-11-04
JP2006514982A (ja) 2006-05-18
MXPA05010010A (es) 2006-03-10
CA2519772A1 (fr) 2004-11-04
CN1758904A (zh) 2006-04-12
CA2746531C (fr) 2016-06-28
AU2003220467A1 (en) 2004-11-19
EP1605929B1 (fr) 2014-04-23
KR20060005345A (ko) 2006-01-17
AU2010202751A1 (en) 2010-07-22
KR101113005B1 (ko) 2012-02-24
EP1605929A1 (fr) 2005-12-21
CA2519772C (fr) 2016-05-31
WO2004093864A1 (fr) 2004-11-04

Similar Documents

Publication Publication Date Title
RU2356547C2 (ru) Способы лечения рака с использованием ингибиторов hdac
WO2008157103A3 (fr) Formes de dosage solides ou semi-solides à libération modifiée
EA200501849A1 (ru) Производные пиразолохиназолина: способ получения и применение в качестве ингибиторов киназ
WO2008064192A3 (fr) Suspensions analgésiques à libération modifiée
DK1519724T3 (da) Fredericamycin-derivater som lægemidler til behandling af tumorer
NO20061506L (no) Heterocykliske inhibitorer av MEK og fremgangsmater for anvendelse derav
WO2007078874A3 (fr) Formulations pharmaceutiques à usage oral contenant des médicaments anti-inflammatoires non stéroïdiens et des inhibiteurs d'acides
TR200002786T2 (tr) Meloksikam için yeni galenik bir formülasyon.
CY1109229T1 (el) Χρηση σπογγοσινης (2-μεθοξυαδενοσινης) για τη θεραπεια πονου, συγκεκριμενα υπερευαισθησιας στο πονο
WO2004071400A3 (fr) Inhibiteurs d'histone desacetylase de nouveaux derives de benzamide a differenciation puissante et a activite inhibant la proliferation
EA200301200A1 (ru) Проникающая через кожу композиция селективного ингибитора циклооксигеназы-2
WO2007075554A3 (fr) Traitement combine avec une composition d’inhibiteur de proteine kinase heterobicyclique a noyau 6,6-bicyclique et d'agents anticancereux
AR033423A1 (es) Sales farmaceuticas constituidas de una sustancia activa farmaceutica y al menos un edulcorante, medicamentos que contienen estas sales y uso de estas sales para la preparacion de medicamentos
BRPI0418029B8 (pt) formulação farmacêutica líquida, estável, adequada para administração parentérica que compreende um anticorpo agonista de cd40
NO20080220L (no) Formuleringer med hoy medikament belastning og doseringsformer
NO20074109L (no) Intravenose formuleringer av PDE-5 inhibitorer
DK1678162T3 (da) P-glycoprotein-inhibitor, fremgangsmåde til fremstilling heraf og farmaceutisk sammensætning omfattende denne
GB0222514D0 (en) Organic compounds
NO20055891L (no) Kinazolinderivater som aurorakinaseinhibitorer
NO20050060L (no) Medikament for behandling av overaktiv blaere
NO20055173L (no) Farmasoytisk kombinasjonsblanding omfattende modafinil og et annet legemiddel
NO20062450L (no) Analgesiske suspensjoner med kontrollert frigivelse
NO20054646L (no) Doseringskur for ikke-steroidalt anti-inflammatorisk legemiddel
WO2004100893A3 (fr) Methodes de traitement d'affections inflammatoires a l'aide de ct-3 ou de ses analogues
EA200401319A1 (ru) Новые гетероциклические соединения, способы их получения и фармацевтические композиции, содержащие эти соединения, и их использование в медицине

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application